Autres langues Biomerica, Inc.

Actions

BMRA

US09061H3075

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 23/04/2024			Varia. 5j.	Varia. 1 janv.
0,722 ^USD	-0,37 %		-2,21 %	-42,24 %

15/04	Biomerica fait le point sur l'expansion de inFoods IBS	CI
12/04	Biomerica, Inc. annonce ses résultats pour le troisième trimestre et les neuf mois terminés le 29 février 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Biomerica Reports Third Quarter 2024 Financial Results	15/04
Biomerica provides update on inFoods® IBS expansion	15/04
Biomerica Provides Update on inFoods IBS Expansion	15/04
Biomerica Reports Third Quarter 2024 Financial Results	13/04
Biomerica, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024	12/04
Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference	28/03
Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board	21/02
Biomerica, Inc. Announces the Appointment of Gary Huff to Its Strategic Advisory Board	21/02
Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica	23/01
Biomerica, Inc. Appoints Jack Kenny as Chairman of the Board of Directors	23/01
Biomerica Reports Second Quarter 2024 Financial Results	16/01
Biomerica, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2023	16/01
Top Premarket Decliners	19/12
Biomerica Shares Rise After FDA 510(k) Clearance for H Pylori Bacteria Test	18/12
Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population	18/12
Biomerica, Inc. Receives US FDA 510(k) Clearance for their Hp Detect Stool Antigen ELISA Test Product Designed to Detect Presence of H. Pylori Bacteria	18/12
Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16	10/11
Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups	08/11
Biomerica, Inc. Expands in Foods IBS Reach with Addition of Several New GI Groups	08/11
Biomerica Reports First Quarter 2024 Financial Results	16/10/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Biomerica, Inc.

Actions

BMRA

US09061H3075

Autres langues

Filtres